Stock listing

NASDAQ:OREX Orexigen Therapeutics Inc Stock

Follow Orexigen Therapeutics Inc into a list and get an email when it puts out news.

Delisted NASDAQ:OREX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:OREX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Orexigen Therapeutics Inc on 6ix

Decks
24 decks · latest Jan 19, 2018

Where Orexigen Therapeutics Inc is listed

ListingExchangeCountryCurrency
NASDAQ:OREX · This page · DelistedNASDAQUnited StatesUSD
OTC:OREXQ · DelistedOTCUnited StatesUSD

Decks

DeckKindSlidesDate
Corporate Update (January 2018)Corporate update17 slidesJan 19, 2018
Corporate Update (January 2018)Corporate update21 slidesJan 8, 2018
BIO Investor Forum 2017Conference32 slidesOct 16, 2017
Cantor Fitzgerald Healthcare Conference 2017Conference36 slidesSep 26, 2017
Corporate Update (March 2017)Corporate update56 slidesMar 8, 2017
Investor Conferences February 13-17, 2017Conference55 slidesFeb 9, 2017
J.P. Morgan 35th Annual Healthcare Conference (January 2017)Conference42 slidesJan 12, 2017
J.P. Morgan 35th Annual Healthcare Conference (January 2017)Conference40 slidesJan 9, 2017
Merger or Acquisition (March 2016)Merger or acquisition43 slidesMar 15, 2016
J.P. Morgan 34th Annual Healthcare Conference 2016Conference28 slidesJan 11, 2016
All 24 decks
DeckKindSlidesDate
Q3 2015 Earnings PresentationEarnings30 slidesNov 5, 2015
JP Morgan Healthcare Conference 2015Conference22 slidesJan 12, 2015
Investor Presentation (January 2014)Investor deck43 slidesJan 13, 2014
Investor Presentation (September 2012)Investor deck32 slidesSep 20, 2012
Investor Presentation (September 2012)Investor deck31 slidesSep 5, 2012
2012 JPMorgan Annual Healthcare ConferenceConference31 slidesJan 10, 2012
JMP Securities Healthcare Conference 2011Conference25 slidesSep 27, 2011
Investor Presentation (December 2010)Investor deck25 slidesDec 17, 2010
Investor Presentation (April 2010)Investor deck66 slidesApr 13, 2010
28th Annual JP Morgan Healthcare Conference (January 2010)Conference30 slidesJan 11, 2010
Technical Presentation (September 2009)Technical16 slidesSep 30, 2009
Technical Presentation (July 2009)Technical22 slidesJul 20, 2009
Investor Presentation (June 2009)Investor deck37 slidesJun 2, 2009
Technical Presentation (January 2009)Technical14 slidesJan 9, 2009

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Wendy L Dixon
Other companies: Zevra Therapeutics, Inc. (Director · Since at least Apr 25, 2023); Iovance Biotherapeutics, Inc. (Director · Jun 10, 2022 – Jun 10, 2022 · Past); Black Diamond Therapeutics, Inc. (Director · Apr 6, 2022 – Mar 15, 2024 · Past); Arvinas, Inc. (Director · Jun 29, 2020 – Jun 15, 2023 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Voyager Therapeutics, Inc. (Director · Jan 1, 2017 – Jun 4, 2020 · Past); Eleven Biotherapeutics Inc (Director · Oct 22, 2014 – May 19, 2017 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past); Ardea Biosciences Inc (Director · Apr 6, 2011 – Jun 19, 2012 · Past); Alkermes plc (Director · Jan 13, 2011 – Jun 14, 2022 · Past); Furiex Pharmaceuticals Inc (Director · May 27, 2010 – Jul 2, 2014 · Past); Incyte Corporation (Director · May 21, 2010 – Mar 31, 2022 · Past); Dentsply Sirona Inc. (Director · Jul 31, 2007 – Jul 8, 2010 · Past); Bristol-Myers Squibb Company (CMO & Pres, Global Marketing · Mar 7, 2006 – May 22, 2006 · Past)
Director · Apr 20, 2010 – Jun 9, 2015 · Past
Lota S Zoth
Other companies: First Financial Bankshares, Inc. (Director · Since at least Apr 28, 2026); enGene Therapeutics Inc. (Director · Since at least Dec 18, 2023); 89bio Inc (Director · Since at least Jun 1, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2019); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Spark Therapeutics Inc (CHIEF SCIENTIFIC OFFICER, Director · Jan 6, 2016 – Dec 17, 2019 · Past); Lumos Pharma Inc (Director · Nov 2, 2012 – Dec 12, 2024 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – May 7, 2015 · Past); Medimmune Inc (SVP, Chief Financial Officer · Feb 23, 2006 – Jun 18, 2007 · Past)
Director · Apr 26, 2012 – Jul 14, 2017 · Past
Preston Klassen
Other companies: Regulus Therapeutics Inc (President & Head of R & D, Director · Since at least Jun 12, 2023); Zura Bio Limited (President and COO · Mar 20, 2023 – Mar 20, 2023 · Past); Metacrine Inc (Director · Sep 15, 2020 – Mar 23, 2023 · Past); Arena Pharmaceuticals Inc (EVP and CMO · Mar 20, 2017 – Mar 1, 2020 · Past); Histogen Inc (Director · Feb 7, 2014 – Jun 27, 2019 · Past)
EVP, Global Development · May 27, 2010 – Feb 2, 2016 · Past
David J. Endicott
Other companies: Alcon AG (Chief Executive Officer · Since at least Aug 10, 2026); MiniMed Group, Inc. (Director · Since at least Jun 29, 2026); Zeltiq Aesthetics Inc (Director · Apr 25, 2016 – Apr 28, 2017 · Past); Hospira Inc (Pres., Hospira Medical Devices · Mar 10, 2014 – Sep 3, 2015 · Past)
Director · Nov 29, 2012 – Jul 14, 2017 · Past
Debora Jorn
Other companies: EyePoint, Inc. (EVP, Corp. & Comm'l Dev. · Nov 2, 2016 – Jun 27, 2017 · Past); Viveve Medical, Inc. (Director · Aug 22, 2016 – Jan 3, 2023 · Past); Bausch Health Companies Inc. (EVP, Company Group Chairman · May 20, 2015 – Nov 20, 2015 · Past)
Director · May 20, 2016 – Jul 14, 2017 · Past
Dennis Kim
Other companies: Skye Bioscience, Inc. (Chief Medical Officer · Aug 21, 2019 – Aug 7, 2020 · Past); Sesen Bio Inc (Chief Medical Officer · Dec 3, 2018 – Dec 3, 2018 · Past); Larimar Therapeutics, Inc. (Chief Medical Officer · Jun 18, 2014 – Jan 22, 2019 · Past)
Sr. VP, Corporate Development · Feb 27, 2009 – Apr 23, 2009 · Past
Michael Narachi
Other companies: Ultragenyx Pharmaceutical Inc. (Director · Since at least Feb 20, 2015); Eiger Biopharmaceuticals Inc (Director · Jan 29, 2014 – Jun 4, 2015 · Past); AMAG Pharmaceuticals Inc (Director · Nov 27, 2007 – May 23, 2013 · Past)
CEO & President, Director · Mar 31, 2009 – Oct 13, 2017 · Past
Peter Honig
Other companies: Karyopharm Therapeutics Inc. (Director · Dec 3, 2021 – May 24, 2023 · Past); Sesen Bio Inc (Director · Jul 20, 2021 – Jun 22, 2022 · Past); Eiger Biopharmaceuticals Inc (Director · Mar 2, 2014 – Jun 4, 2015 · Past)
Director · Jun 5, 2013 – Jul 14, 2017 · Past
Louis C Bock
Other companies: Horizon Pharma PLC (Director · Jul 28, 2011 – Aug 2, 2011 · Past); Zogenix Inc (Director · Nov 22, 2010 – Mar 7, 2022 · Past)
Director · May 27, 2010 – Jul 14, 2017 · Past
Thomas P Lynch
Other companies: BillionToOne, Inc. (See Remarks · Since at least Nov 5, 2025); Nuwellis, Inc. (Chief Legal Compliance Officer · May 20, 2020 – Jan 22, 2021 · Past)
EVP, Chief Admin Off, GC & Sec · Jul 12, 2016 – Oct 13, 2017 · Past
All 14 people
PersonSeat
Peter D Flynn
Other companies: Fate Therapeutics, Inc. (See remarks · Sep 30, 2013 – Jan 5, 2015 · Past)
EVP, Head of Global Dev · Jun 8, 2016 – Oct 13, 2017 · Past
Carol A BaumVP, Commercialization · Feb 27, 2009 – Apr 23, 2009 · Past
Mark D BoothChief Commercial Officer · Sep 1, 2010 – Feb 26, 2015 · Past
Stephen A MogliaVP & Chief Accounting Officer · Dec 11, 2015 – Mar 15, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Orexigen Therapeutics Inc.